Addition of bevacizumab to chemotherapy in advanced non-small cell lung cancer: a systematic review and meta-analysis.

PLoS One · 2011 · PMC3149053 · PMID 21829644

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

In NSCLC, high levels of VEGF expression are associated with a poor prognosis [5] , suggesting that treatment targeted toward this pathway might be significant therapeutically.

also in 2,457 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.